Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment

To measure preferences of women with ovarian cancer regarding risks, side effects, costs and benefits afforded by maintenance therapy (MT) with a poly ADP ribose polymerase (PARP) inhibitor. A discrete-choice experiment elicited preferences of women with ovarian cancer regarding 6 attributes (levels...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gynecologic oncology 2020-03, Vol.156 (3), p.561-567
Hauptverfasser:	Havrilesky, Laura J., Lim, Stephanie, Ehrisman, Jessie A., Lorenzo, Amelia, Alvarez Secord, Angeles, Yang, Jui-Chen, Johnson, F. Reed, Gonzalez, Juan Marcos, Reed, Shelby D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Benefit Cost Maintenance therapy PARP inhibitors Patient preferences Risk
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!